Feng-Ming Spring Kong 1, Chen Hu 2 3, Daniel A Pryma 4, Fenghai Duan 5, Martha Matuszak 6, Ying Xiao 4, Randall Ten Haken 6, Marilyn J Siegel 7, Lucy Hanna 5, Walter J Curran 8, Mark Dunphy 9, Daphna Gelblum 10, Morand Piert 6, Shruti Jolly 6, Clifford G Robinson 7, Andrew Quon 11, Billy W Loo 12, Shyam Srinivas 13, Gregory M Videtic 14, Sergio L Faria 15, Catherine Ferguson 16, Neal E Dunlap 17, Vijayananda Kundapur 18, Rebecca Paulus 2 19, Barry A Siegel 7, Jeffrey D Bradley 4, Mitchell Machtay 20 Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Position Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer , Journal of Clinical Oncology: 2024
Wei Liu PhD ⁎, , Hongying Feng PhD ⁎ † ‡, , Paige A. Taylor MS §, , Minglei Kang PhD ║, , Jiajian Shen PhD ⁎, , Jatinder Saini PhD ¶, , Jun Zhou PhD #, , Huan B. Giap MD, PhD ⁎⁎, , Nathan Y. Yu MD ⁎, , Terence S. Sio MD ⁎, , Pranshu Mohindra MD ††, , Joe Y. Chang MD ‡‡, , Jeffrey D. Bradley MD §§, , Ying Xiao PhD §§, , Charles B. Simone II MD ║, , Liyong Lin PhD #, ⁎, Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies , International Journal of Radiation Oncology*Biology*Physics, 119: 2024,1208-1221
Nathan Harrison PhD *, Minglei Kang PhD †, Ruirui Liu PhD ⁎ ‡, Serdar Charyyev PhD §, Niklas Wahl PhD ║, Wei Liu PhD ¶, Jun Zhou PhD *, Kristin A. Higgins MD *, Charles B. Simone II MD †, Jeffrey D. Bradley MD #, William S. Dynan PhD *, Liyong Lin PhD * A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters , International Journal of Radiation Oncology*Biology*Physics
: 2024
Jimmy S. Patel MD, PhD 1, Neal S. McCall MD 2, Matthew Thomas MS 1, Jun Zhou PhD 1, Kristin A. Higgins MD 1, Jeffrey D. Bradley MD 3, Sibo Tian MD 1, Mark W. McDonald MD 1, Aparna H. Kesarwala MD, PhD 1, William A. Stokes MD Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC , International Journal of Particle Therapy: 2024
Michelle Iocolano MD, Nikhil Yegya-Raman MD, Cole Friedes MD, Xingmei Wang MS, Timothy Kegelman MD, PhD, Sang Ho Lee PhD, Lian Duan MS, Bolin Li BS, William P. Levin MD, Keith A. Cengel MD PhD, Andre Konski MD, Corey J. Langer MD, Roger B. Cohen MD, Lova Sun MD, Charu Aggarwal MD, Abigail Doucette MPH, Ying Xiao PhD, Boon-Keng Kevin Teo PhD, Shannon O’Reilly PhD, Wei Zou PhD, Jeffrey D. Bradley MD, Charles B. Simone II MD, Steven J. Feigenberg MD Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era , Cancer: 2024
Puneeth Iyengar, Chen Hu, Daniel Richard Gomez, Robert D. Timmerman, Charles B. Simone II, Clifford Grant Robinson, David E Gerber, Saiama Naheed Waqar, Jessica Donington, Stephen Swisher, Michael Weldon, Jackie Wu, Bryan A. Faller, Sawsan Rashdan, Kevin L. Stephans, Pamela Sampson, Kristin Ann Higgins, Ryan Kenneth Nowak, Jessica Lyness, and Jeffrey D. Bradley NRG-LU002: Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC). , Journal of Clinical Oncology: 2024
Adam Barsouk 1 #, Cole Friedes 2 #, Michelle Iocolano 2, Abigail Doucette 2, Roger B. Cohen 1, Kyle W. Robinson 1, Christopher A. D'Avella 1, Melina E. Marmarelis 1, John A. Kosteva 1, Aditi P. Singh 1, Christine A. Ciunci 1, William P. Levin 2, Keith A. Cengel 2, Jeffrey D. Bradley 2, Steven J. Feigenberg 2, Lova Sun 1, Charu Aggarwal 1, Corey J. Langer 1, Nikhil Yegya-Raman 2 Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation , Clinical Lung Cancer: 2024
James J. Dignam, Paul A Romitti, Sue S. Yom, Felix Y Feng, Jeffrey D. Bradley, Minesh P. Mehta, Deborah Watkins Bruner, Jennifer Wenzel, Eleftherios P. Mamounas, Thomas J. George, Theodore S. Hong, Carol Aghajanian, Maria Werner-Wasik, and Alexandra Thomas Racial/ethnic distribution of participants in NRG oncology clinical trials: 2014-2023. , Journal of Clinical Oncology: 2024
Yuan Gao, Chih-Wei Chang, Sagar Mandava, Raanan Marants, Jessica E. Scholey, Matthew Goette, Yang Lei, Hui Mao, Jeffrey D. Bradley, Tian Liu, Jun Zhou, Atchar Sudhyadhom & Xiaofeng Yang MRI-only based material mass density and relative stopping power estimation via deep learning for proton therapy: a preliminary study , Scientific reports: 2024
Nikhil Yegya-Raman MD *, Abigail T. Berman MD, MSCE *, Christine A. Ciunci MD †, Cole Friedes MD *, Eva Berlin MD *, Michelle Iocolano MD *, Xingmei Wang MS ‡, Ching Lai BA *, William P. Levin MD *, Keith A. Cengel MD, PhD *, Shannon E. O'Reilly PhD *, Roger B. Cohen MD †, Charu Aggarwal MD, MPH †, Melina E. Marmarelis MD, MSCE †, Aditi P. Singh MD †, Lova Sun MD, MSCE †, Jeffrey D. Bradley MD *, John P. Plastaras MD, PhD *, Charles B. Simone II MD § ║, Corey J. Langer MD †…Steven J. Feigenberg MD * Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer , International Journal of Radiation Oncology*Biology*Physics
: 2024
